SCHEMBL6807486

SCHEMBL6807486

CCCc1cc(-c2nc3cccc(C(N)=O)c3[nH]2)on1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.38
DAPK3 O43293 2/20 0.38
CDK5 Q00535 2/20 0.38
ROCK1 Q13464 2/20 0.38
AURKB Q96GD4 2/20 0.38
JAK2 O60674 1/20 0.38
ROCK2 O75116 1/20 0.38
CHEK2 O96017 1/20 0.38
PIM1 P11309 1/20 0.38
CDK2 P24941 1/20 0.38
MARK3 P27448 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
LIMK1 P53667 1/20 0.38
DYRK1A Q13627 1/20 0.38
PRKD2 Q9BZL6 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PARP1 P09874 10/20 0.35
PARP2 Q9UGN5 1/20 0.35
PLK4 O00444 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805937 0.86 PLK4 (0.39) AURKADAPK3CDK5ROCK1AURKB
SCHEMBL6807483 0.83 PARP1 (0.53) ROCK1AURKBROCK2CHEK2PIM1
SCHEMBL6804675 0.81 PARP1 (0.36) AURKADAPK3CDK5ROCK1KDM4E
SCHEMBL6805212 0.80 PARP1 (0.39) AURKADAPK3CDK5ROCK1PARP1
SCHEMBL6805469 0.78 NPC1 (0.43) CHEK2PARP1NPC1RAB9A
SCHEMBL6807302 0.75 TRPV1 (0.42) PARP1RAB9AMAPT
SCHEMBL6806365 0.74 PARP1 (0.54) AURKADAPK3CDK5ROCK1AURKB
SCHEMBL6807466 0.73 ALDH1A1 (0.42) AURKADAPK3CDK5ROCK1KDM4E
SCHEMBL6587689 0.72 PARP1 (0.39) AURKADAPK3CDK5ROCK1AURKB
SCHEMBL7137491 0.70 PARP1 (0.47) CHEK2PARP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696437-B1 Heterocyclically substituted benzimidazoles, the production and application thereof ABBOTT GMBH & CO. KG (DE) 2004-02-24 US disclosed